Pharmaceutical and biotechnology work is heavily regulated because the products affect human health. Compliance in this context means operating in line with the quality, safety and data rules that apply to the facility — not a promise that any particular inspection will pass.
What it usually covers
Patient safety and product quality, including Good Manufacturing Practice (GMP) from materials through to release.
Data integrity for research, development and manufacturing records, so that decisions can be reconstructed.
Good Clinical Practice (GCP) where trials are run, protecting participants and the scientific record.
Supply-chain controls that reduce contamination and falsification risks.
The ability to meet the different regulatory files required in the countries where a product is placed.
Why facilities invest in it
Market access depends on it. Failures can lead to recalls, legal action and loss of authorisation.
Inspectors, customers and investors look for a working quality system, not a slogan. Continuous review of procedures as regulations and methods change is part of that system.